http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0559005-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_382ccfc2ebebcaee15aa7cda4cee86bc |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
filingDate | 1992-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f7482d9896e0775476aad25a3f2c775 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de7d9d3a384e4ea7e19e0faaa8b2c8d8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_108d076a51e2c75d1f7480ff04c8912f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b163bdda117c911a34f8c2c941cba51 |
publicationDate | 1993-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-H0559005-A |
titleOfInvention | Cardiotonic |
abstract | (57) [Summary] (Corrected) [Configuration] General formula below [In the formula, R 1 is a hydrogen atom or a cyano group, and R is a group —NR 2 R 3 , R 2 and R 3 represent a hydrogen atom, a lower alkyl group which may have a hydroxyl group as a substituent, a cycloalkyl group, etc.] and a cardiotonic agent containing a carbostyril derivative represented by Agents, antihypertensive agents, vasoconstriction inhibitors, anti-inflammatory agents. [Effect] The above carbostyril derivative and its salt are It has an action of enhancing myocardial contraction (positive inotropic action), an action of increasing coronary blood flow, an antihypertensive action, an action of suppressing vasoconstriction by norepinephrine, and an anti-inflammatory action, such as congestive heart failure, mitral valvular disease, and atria. It is useful as a cardiotonic agent, antihypertensive agent, and anti-inflammatory agent for the treatment of various heart diseases such as sexual fibrillation, flutter, paroxysmal atrial tachycardia. |
priorityDate | 1992-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 195.